Abstract

Non-cardiac surgeries account for nearly 85% of the to­tal 300 million surgeries that are performed annually world­wide, cardiovascular events representing the main source of perioperative morbidity and mortality. Considering that often patients suffering from cardiovascular (CV) di­sea­ses tend be clinically fragile, clear recommendations are needed to guide clinical decisions, in order to minimize their perioperative risk. The current ESC guideline main­tains some of the classic indications, emphasizing the im­por­tance of preoperative risk assessment and clinical exa­mi­na­tion of the patients suffering from a CV disease. It also introduces new concepts regarding the preoperative use of biomarkers, the perioperative thromboprophylaxis and the management of patients newly diagnosed with mur­murs, dyspnea, oedema or angina. Furthermore, other sec­tions, approaching complex clinical situations, as peri-ope­ra­tive management of antiplatelet and anti­coagulant the­ra­pies, have been revised, according to the latest studies. This review is meant to concisely present these new recom­men­da­tions, in a simplified and more accessible manner.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.